Pura Vida Investments 13F annual report

Pura Vida Investments is an investment fund managing more than $82.7 billion ran by Cara Bradfield. There are currently 25 companies in Mrs. Bradfield’s portfolio. The largest investments include Establishment Labs Inc and Glaukos, together worth $20.8 billion.

$82.7 billion Assets Under Management (AUM)

As of 7th August 2024, Pura Vida Investments’s top holding is 230,093 shares of Establishment Labs Inc currently worth over $10.5 billion and making up 12.6% of the portfolio value. Relative to the number of outstanding shares of Establishment Labs Inc, Pura Vida Investments owns more than approximately 0.1% of the company. In addition, the fund holds 87,000 shares of Glaukos worth $10.3 billion, whose value grew 28.1% in the past six months. The third-largest holding is Intuitive Surgical Inc worth $8.41 billion and the next is Natera Inc worth $7.31 billion, with 67,500 shares owned.

Currently, Pura Vida Investments's portfolio is worth at least $82.7 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Pura Vida Investments

The Pura Vida Investments office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Cara Bradfield serves as the Chief Financial Officer and Chief Compliance Officer at Pura Vida Investments.

Recent trades

In the most recent 13F filing, Pura Vida Investments revealed that it had opened a new position in Icu Med Inc and bought 29,334 shares worth $3.48 billion.

The investment fund also strengthened its position in Glaukos by buying 8,000 additional shares. This makes their stake in Glaukos total 87,000 shares worth $10.3 billion. Glaukos soared 64.4% in the past year.

On the other hand, there are companies that Pura Vida Investments is getting rid of from its portfolio. Pura Vida Investments closed its position in Exact Sciences on 14th August 2024. It sold the previously owned 481,910 shares for $33.3 billion. Cara Bradfield also disclosed a decreased stake in Establishment Labs Inc by 0.1%. This leaves the value of the investment at $10.5 billion and 230,093 shares.

One of the smallest hedge funds

The two most similar investment funds to Pura Vida Investments are Covey Capital Advisors and Canaan Partners Xi. They manage $82.8 billion and $82.6 billion respectively.

Cara Bradfield investment strategy

Pura Vida Investments’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 83.2% of the total portfolio value. The fund focuses on investments in the United States as 60.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 8% of the total holdings value. On the other hand, large-cap stocks make up only 4.0% of the portfolio. The average market cap of the portfolio companies is close to $7.94 billion.

The complete list of Pura Vida Investments trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Exact Sciences Corp.	Closed 481,910	$33,280,705,000
Establishment Labs Holdings Inc	12.07% 230,093	$10,455,426,000	12.64%
Glaukos Corporation	10.13% 87,000	$10,296,450,000	12.45%
Lyra Therapeutics, Inc.	Closed 1,413,242	$8,790,365,000
Intuitive Surgical Inc	21.41% 18,900	$8,407,665,000	10.17%
Natera Inc	5.73% 67,500	$7,309,575,000	8.84%
Advisorshares Tr	35.69% 787,000	$5,768,710,000	6.98%
Quanterix Corp	8.87% 409,334	$5,407,302,000	6.54%
LivaNova PLC	13.09% 78,350	$4,295,147,000	5.19%
Dexcom Inc	Closed 30,000	$4,161,000,000
Icu Med Inc	Opened 29,334	$3,483,413,000	4.21%
Castle Biosciences, Inc.	Opened 153,386	$3,339,213,000	4.04%
Viking Therapeutics Inc	Closed 39,868	$3,269,176,000
Pulmonx Corp	9.89% 512,964	$3,252,192,000	3.93%
Inspire Med Sys Inc	Closed 15,000	$3,221,850,000
Masimo Corp	Opened 25,000	$3,148,500,000	3.81%
Shockwave Med Inc	Closed 8,771	$2,856,101,000
Alphatec Holdings Inc	37.82% 199,000	$2,079,550,000	2.51%
Bruker Corp	Opened 32,500	$2,073,825,000	2.51%
Repligen Corp.	Closed 11,225	$2,064,502,000
Guardant Health Inc	Closed 100,000	$2,063,000,000
Cutera Inc	8.07% 1,165,799	$1,760,356,000	2.13%
Tandem Diabetes Care Inc	4.71% 40,500	$1,631,745,000	1.97%
Bioventus Inc	Opened 280,000	$1,610,000,000	1.95%
Edwards Lifesciences Corp	Closed 15,408	$1,472,388,000
Oncocyte Corporation	5.46% 495,345	$1,461,268,000	1.77%
Staar Surgical Co.	Opened 30,000	$1,428,300,000	1.73%
10x Genomics, Inc.	Closed 38,005	$1,426,328,000
Baxter International Inc.	Closed 30,000	$1,282,200,000
Zimvie Inc	4.23% 70,000	$1,277,500,000	1.54%
Treace Med Concepts Inc	Closed 89,897	$1,173,156,000
InspireMD Inc	No change 450,517	$1,124,175,000	1.36%
Metagenomi Inc	41.33% 270,618	$1,038,964,000	1.26%
Myriad Genetics, Inc.	Closed 44,725	$953,537,000
Elanco Animal Health Inc	70.71% 56,603	$816,781,000	0.99%
AVITA Medical Inc	Closed 35,000	$561,050,000
Twist Bioscience Corp	Opened 10,000	$492,800,000	0.60%
Inari Med Inc	Opened 10,000	$481,500,000	0.58%
Genedx Holdings Corp	Opened 10,000	$261,400,000	0.32%
No transactions found
Showing first 500 out of 39 holdings